Tuis524715 • BOM
add
Sun Pharmaceutical Industries Ltd
Vorige sluiting
₹1 777,65
Dagwisseling
₹1 768,00 - ₹1 815,65
Jaarwisseling
₹1 185,25 - ₹1 960,20
Markkapitalisasie
4,32 bn INR
Gemiddelde volume
50,62 k
P/V-verhouding
38,98
Dividend-opbrengs
0,75%
Primêre beurs
NSE
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (INR) | Sep. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 132,91 mjd | 9,01% |
Bedryfskoste | 74,12 mjd | 8,61% |
Netto inkomste | 30,40 mjd | 27,98% |
Netto winsgrens | 22,87 | 17,40% |
Wins per aandeel | 12,70 | 28,28% |
EBITDA | 38,25 mjd | 18,70% |
Effektiewe belastingkoers | 15,74% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (INR) | Sep. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 201,22 mjd | 35,66% |
Totale bates | 881,16 mjd | 10,92% |
Totale aanspreeklikheid | 187,36 mjd | 15,34% |
Totale ekwiteit | 693,80 mjd | — |
Uitstaande aandele | 2,39 mjd | — |
Prys om te bespreek | 6,16 | — |
Opbrengs op bates | — | — |
Opbrengs op kapitaal | 11,19% | — |
Kontantvloei
Netto kontantverandering
| (INR) | Sep. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | 30,40 mjd | 27,98% |
Kontant van bedrywe | — | — |
Kontant van beleggings | — | — |
Kontant van finansiering | — | — |
Netto kontantverandering | — | — |
Beskikbare kontantvloei | — | — |
Meer oor
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients in more than 100 countries across the globe. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world. The products cater to a vast range of therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynecology, respiratory, oncology, dental and nutritionals. Wikipedia
Gestig
1983
Hoofkwartier
Webwerf
Werknemers
43 000
